IISc-incubated Mynvax 
Dealstreet

Argus, IndusLaw acts on Mynvax $4.2 million fund raise from Accel and others

LetsVenture and a few early-stage angel investors also participated in this round.

Bar & Bench

Mynvax, a vaccine technology startup, incubated by the Society for Innovation and Development (SID) has raised $4.2 million (₹31 crores) in its Series A funding round led by Accel.

Argus Partners advised Mynvax and the team was led by Partner Vinod Joseph along with Associate Anurag Prasad.

IndusLaw acted for Accel and the team was led by Partner Anindya Ghosh. along with Principal Associate Ashwin Krishnan and Associate Manisha Nayak.

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.

Also Read

Karnataka court restrains Kamal Haasan from making defamatory statements about Kannada

SEZ Rules relaxed: A shot in the arm for India’s semiconductor ambitions?

Anticipatory bail provisions under BNSS apply retrospectively, override CrPC restrictions: Allahabad High Court

PIL in Kerala High Court over Kottayam Medical College building collapse

Karnataka High Court grants interim relief to BJP MLC Ravikumar booked for insulting Chief Secretary

SCROLL FOR NEXT